Apothecary Capital

Apothecary Capital

Apothecary Capital

Suggest edits
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 3

Portfolio

Portfolio Tracker

Add info
MedCity News

Alexion plunks down $1.4B to acquire Portola Pharmaceuticals

Portola Pharma
Portola Pharma
Xconomy

FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits

Health Science
FibroGen
FibroGen
$62,000,000 Post-IPO equity
biospace

FibroGen Gets 62 Million License Payment from Partner AstraZeneca PLC

Health Science